Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infections

Mycobacterium tuberculosis has diminished capacity to counteract redox stress induced by elevated levels of endogenous superoxide

(2015) Priyanka Tyagi et al.   FREE RADICAL BIOLOGY AND MEDICINE

Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

(2015) Rodney Dawson et al.   LANCET

Early versus Delayed Antiretroviral Therapy for HIV and Tuberculosis Co-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2015) Shipeng Yan et al.   PLoS One

Pharmacological Interactions Between Rifampicin and Antiretroviral Drugs

(2015) Hadija H. Semvua et al.   THERAPEUTIC DRUG MONITORING

Prolonged-acting, Multi-targeting Gallium Nanoparticles Potently Inhibit Growth of Both HIV and Mycobacteria in Co-Infected Human Macrophages

(2015) Prabagaran Narayanasamy et al.   Scientific Reports

Efflux Pump Gene Expression in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates

(2015) Guilian Li et al.   PLoS One

Tuberculosis distorts the inhibitory impact of interleukin-10 in HIV infection

(2014) Shivan Chetty et al.   AIDS

Energy Metabolism and Drug Efflux in Mycobacterium tuberculosis

(2014) P. A. Black et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synthesis of nanodiamond derivatives carrying amino functions and quantification by a modified Kaiser test

(2014) Gerald Jarre et al.   Beilstein Journal of Organic Chemistry

Treatment Optimization in Patients Co-Infected with HIV and Mycobacterium tuberculosis Infections: Focus on Drug–Drug Interactions with Rifamycins

(2014) Mario Regazzi et al.   CLINICAL PHARMACOKINETICS

Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system

(2014) Bruno Sarmento et al.   International Journal of Nanomedicine

Research and Services Partnerships: Responding to Needs of Clinical Operations Partners: Transferring Implementation Facilitation Knowledge and Skills

(2014) Mona J. Ritchie et al.   PSYCHIATRIC SERVICES

Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review

(2013) Alejandro Sosnik   ADVANCED DRUG DELIVERY REVIEWS

Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy

(2013) Nagsen Gautam et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice

(2012) Prasanta K. Dash et al.   AIDS

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

(2012) Karthika Natarajan et al.   BIOCHEMICAL PHARMACOLOGY

HIV-1 gp120 and Drugs of Abuse: Interactions in the Central Nervous System

(2012) Peter S. Silverstein et al.   CURRENT HIV RESEARCH

Structural and Functional Properties of Human Multidrug Resistance Protein 1 (MRP1/ABCC1)

(2012) S.-M. He et al.   CURRENT MEDICINAL CHEMISTRY

The Expression of ABC Efflux Pump, Rv1217c–Rv1218c, and Its Association with Multidrug Resistance of Mycobacterium tuberculosis in China

(2012) Ke Wang et al.   CURRENT MICROBIOLOGY

Pharmacodynamic and Antiretroviral Activities of Combination Nanoformulated Antiretrovirals in HIV-1–Infected Human Peripheral Blood Lymphocyte–Reconstituted Mice

(2012) Upal Roy et al.   JOURNAL OF INFECTIOUS DISEASES

Initiating antiretrovirals during tuberculosis treatment: a drug safety review

(2011) Tanuja N Gengiah et al.   Expert Opinion On Drug Safety

Redox homeostasis in mycobacteria: the key to tuberculosis control?

(2011) Ashwani Kumar et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

The role of ABC efflux pump, Rv1456c-Rv1457c-Rv1458c, from Mycobacterium tuberculosis clinical isolates in China

(2011) Pei Hao et al.   FOLIA MICROBIOLOGICA

Modulation of the expression of ABC transporters in murine (J774) macrophages exposed to large concentrations of the fluoroquinolone antibiotic moxifloxacin

(2011) Coralie M. Vallet et al.   TOXICOLOGY

Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir

(2009) L. A. Wenning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cooperation between Prokaryotic (Lde) and Eukaryotic (MRP) Efflux Transporters in J774 Macrophages Infected with Listeria monocytogenes: Studies with Ciprofloxacin and Moxifloxacin

(2008) A. Lismond et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Identification of a Novel Multidrug Efflux Pump of Mycobacterium tuberculosis

(2008) O. Danilchanka et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

MRP (ABCC) Transporters-Mediated Efflux of Anti-HIV Drugs, Saquinavir and Zidovudine, from Human Endothelial Cells

(2008) Mark Eilers et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers

(2008) Elena V. Batrakova et al.   JOURNAL OF CONTROLLED RELEASE